| Not Yet Recruiting | PD-1 Monoclonal Antibody Combined With Gemcitabine and Cisplatin Followed by Selective Radiotherapy for Unrese NCT07528183 | Sun Yat-sen University | Phase 2 |
| Not Yet Recruiting | Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasop NCT07524413 | Sun Yat-sen University | Phase 3 |
| Recruiting | Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasoph NCT07362979 | Sun Yat-sen University | Phase 2 |
| Not Yet Recruiting | Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma NCT07385079 | Sun Yat-sen University | Phase 3 |
| Recruiting | Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy NCT07496190 | Sun Yat-sen University | Phase 2 |
| Not Yet Recruiting | MRG003 Combined With Immunotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial NCT07381699 | West China Hospital | Phase 2 |
| Not Yet Recruiting | Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma NCT07373990 | Sun Yat-sen University | Phase 3 |
| Recruiting | IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features NCT07376603 | Qiaojuan Guo | — |
| Recruiting | LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC NCT07325539 | Sun Yat-sen University | Phase 2 |
| Recruiting | Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid NCT07311772 | Sun Yat-sen University | Phase 3 |
| Not Yet Recruiting | Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma NCT07238569 | Sun Yat-sen University | Phase 3 |
| Recruiting | Prospective Immuno-Radiomic Profiling in Nasopharyngeal Carcinoma Treated With Proton or Photon Chemoradiother NCT07232680 | Cheng-En Hsieh | — |
| Recruiting | Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma. NCT07201337 | Sun Yat-sen University | Phase 3 |
| Recruiting | Adaptive Immunotherapy for Nasopharyngeal Carcinoma NCT07154069 | Sun Yat-sen University | Phase 3 |
| Not Yet Recruiting | Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma NCT07129772 | The University of Hong Kong | Phase 2 |
| Active Not Recruiting | Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcin NCT07248696 | Chongqing University Cancer Hospital | N/A |
| Active Not Recruiting | Concurrent Chemoradiotherapy With or Without Metronomic Capecitabine in High-Risk T1-2N1M0 NPC NCT07248670 | Chongqing University Cancer Hospital | Phase 3 |
| Not Yet Recruiting | International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer NCT07013461 | The University of Hong Kong-Shenzhen Hospital | — |
| Not Yet Recruiting | EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma NCT07138989 | Sun Yat-sen University | Phase 2 |
| Not Yet Recruiting | Radiotherapy Omitting Prophylactic Neck Irradiation With Neoadjuvant and Adjuvant Toripalimab in Nasopharyngea NCT07110558 | Sun Yat-sen University | Phase 2 |
| Not Yet Recruiting | Shrinking the Anterior Border of CTV2 for Nasopharyngeal Carcinoma to Reduce the Radiation of Nasal Cavity NCT07072000 | Hai-Qiang Mai,MD,PhD | Phase 3 |
| Recruiting | Reduced Dose Radiotherapy vs Standard Dose Radiotherapy for Early Stage Nasopharyngeal Carcinoma NCT06912698 | Hai-Qiang Mai,MD,PhD | Phase 3 |
| Recruiting | QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carc NCT06749899 | Sun Yat-Sen University Cancer Center | Phase 3 |
| Recruiting | EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma NCT06802835 | Sun Yat-Sen University Cancer Center | Phase 1 / Phase 2 |
| Not Yet Recruiting | GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma NCT06605131 | Sun Yat-sen University | Phase 2 |
| Recruiting | Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC NCT06846450 | Lin Kong, MD | Phase 3 |
| Recruiting | Sodium Bicarbonate for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma. NCT06854510 | Sun Yat-sen University | Phase 2 / Phase 3 |
| Recruiting | Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma NCT06831357 | Sun Yat-sen University | — |
| Recruiting | LDRT and Chemoimmunotherapy in NPC With Liver Metastasis NCT06788002 | Hunan Cancer Hospital | Phase 2 |
| Active Not Recruiting | Impact of Vitamin D on Therapeutic Respons in NPC Chemoradiated Patients NCT07042711 | Indonesia University | N/A |
| Active Not Recruiting | Tertiary Lymphoid Structures in Nasopharyngeal Carcinoma NCT06770699 | Jiangxi Provincial Cancer Hospital | — |
| Recruiting | Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma NCT06669611 | Sun Yat-sen University | Phase 3 |
| Recruiting | A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC) NCT06829147 | Sun Yat-sen University | — |
| Recruiting | SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carci NCT06676722 | The First Affiliated Hospital of Xiamen University | Phase 2 |
| Active Not Recruiting | TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carc NCT06664983 | Sun Yat-sen University | Phase 3 |
| Recruiting | Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy NCT07067268 | Fudan University | Phase 2 |
| Recruiting | A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell NCT05910827 | Hummingbird Bioscience | Phase 1 / Phase 2 |
| Completed | Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus ( NCT02586532 | National Cancer Institute (NCI) | — |